Roche Holding AG (RO.SW)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Severin Schwan Ph.D. | Executive Chairman | 7.51M | -- | 1967 |
| Dr. Thomas Schinecker | Group Chief Executive Officer | 3.87M | -- | 1975 |
| Dr. Alan Hippe | Chief Financial Officer | 4.11M | -- | 1967 |
| Dr. Bruno Eschli | Head of Investor Relations | -- | -- | -- |
| Ms. Claudia Bockstiegel | General Counsel | -- | -- | 1964 |
| Ms. Pascale Schmidt | Chief Compliance Officer | -- | -- | 1973 |
| Ms. Barbara Schadler | Head of Group Communications | -- | -- | 1962 |
| Ms. Cristina A. Wilbur | Chief People Officer | 2.92M | -- | 1967 |
| Dr. Nicolas Dunant | Head of Group Media Relations | -- | -- | -- |
| Mr. Boris L. Zaitra | Head of Corporate Business Development | -- | -- | 1972 |
Roche Holding AG
- Sector:
- Healthcare
- Industry: Drug Manufacturers - General
- Full Time Employees:
- 103,249
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Corporate Governance
Upcoming Events
July 24, 2025 at 5:00 AM UTC
Roche Holding AG Earnings Date
Recent Events
March 31, 2025 at 12:00 AM UTC
Dividend Date
March 27, 2025 at 12:00 AM UTC
Ex-Dividend Date